ID: MRFR/Pharma/1649-HCR | February 2021 | Region: Global | 80 pages
Market Synopsis of Regenerative Medicine Market:
The Global Regenerative Medicine Market is growing steadily. Factors that influence the regenerative medicine market are increasing advancement in healthcare technology, increasing advance technology in regenerative medicine market, increasing prevalence of chronic diseases, increasing growth in stem cell technology and others. Globally the market for regenerative medicine is expected to grow at the rate of about 25.4% from 2016 to 2022.
Key Players for Regenerative Medicine Market:
Some of the key players in this market are: Cook Biotech, Osiris Therapeutics, Organogenesis, Stryker and RTI surgical, Baxter International, Inc., LifeSciences, Advanced Cell Technology, CryoLife, Sanofi, BioMimetic Therapeutics, StemCellsInc, Medtronic, LifeCell Kinetic Concepts and others.
Global regenerative medicine market has been segmented on the basis of material which comprises synthetic materials, genetically engineered materials, pharmaceuticals, biologically derived materials and others. On the basis of therapy the market is segmented into stem cell biology, cellular therapy, tissue engineering and others. Furthermore on the basis of application the market is segmented into cord blood, oncology, urology, orthopedics, neurology, dermatology, cardiovascular, orthopedic and others.
Regional Analysis of Regenerative Medicine Market:
Globally North America is the largest market for regenerative medicine market. North America holds the largest market share of more than 44% of the global regenerative medicine market and is expected to grow at a CAGR of 22.3%. Europe is the second-largest market for Regenerative medicine which is expected to grow at a CAGR of 22.5%. Asia pacific region is expected to be fastest growing region in regenerative medicine market.
Regenerative Medicine Market by Region
Latin America, Middle East & Africa
The report for regenerative medicine market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Frequently Asked Questions (FAQ) :
The global regenerative medicine market is projected grow at approximately 25.4% CAGR during the assessment period (2016-2022).
Increasing incidences of degenerative diseases and shortage of organs for transplantation and increasing utilization of nanomaterials in wound care, drug delivery, and immunomodulation are the major tailwinds pushing the growth of the global regenerative medicine market.
North America holds the largest share in the global regenerative medicine market, followed by Europe and the Asia Pacific, respectively.
Osiris Therapeutics, Inc. (US), Organogenesis Inc. (US), Vericel Corporation (US), NuVasive, Inc. (US), Stryker Corporation (US), Medtronic (Ireland), Integra LifeSciences (US), Acelity (KCI Concepts) (US), Cook Biotech Inc. (US), RTI surgical (US), C.R. Bard (US), Baxter International, Inc. (US), CryoLife (US), Advanced Cell Technology (US), Sanofi (France), StemCells Inc. (US), BioMimetic Therapeutics (US), and LifeCell Kinetic Concepts (US), are some of the major players operating in the regenerative medicine market.
Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global regenerative medicine market adopt to gain a larger competitive advantage.
Table of Contents
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 Global Regenerative medicine Market, by material
5.1.1 Synthetic Materials
5.1.2 Genetically Engineered Materials
5.1.3 Biologically Derived Materials
6. Global Regenerative medicine Market, by Therapy
6.1.1 Stem Cell Biology
6.1.2 Cellular Therapy
6.1.3 Tissue Engineering
7. Global Regenerative medicine Market, by Application
7.1.1 Cord Blood
8 Global Regenerative medicine Market, by regions
8.1.1 North America
126.96.36.199 Rest of Europe
8.1.3 Asia Pacific
188.8.131.52 Republic of Korea
184.108.40.206 Rest of Asia Pacific
8.1.4 Latin America, Middle East & Africa
9 Company Landscape
9.1.1 Mergers Acquisitions
9.1.3 Release/New Product Launches
9.1.4 Other (Expansion, Updates, Partnership)
10 Company Profile
10.1 Cook Biotech.
10.1.1 Company Overview
10.1.2 Product/Business Segment Overview
10.1.4 Key Developments
10.2 Baxter International, Inc
10.2.2 Product/Business Segment Overview
10.2.4 Key Developments
10.3.2 Product/Business Segment Overview
10.3.4 Key Developments
10.4 BioMimetic Therapeutics
10.4.2 Product/Business Segment Overview
10.4.4 Key Developments
10.5.2 Product/Business Segment Overview
10.5.4 Key Developments
10.6.2 Product/Business Segment Overview
10.6.4 Key Developments
10.7 LifeCell Kinetic Concepts
10.7.2 Product/Business Segment Overview
10.7.4 Key Developments
10.8 RTI surgical
10.8.2 Product/Business Segment Overview
10.8.4 Key Developments
10.9 Integra LifeSciences
10.9.2 Product/Business Segment Overview
10.9.4 Key Developments
10.10 Advanced Cell Technology
10.10.2 Product/Business Segment Overview
10.10.4 Key Developments
10.11.2 Product/Business Segment Overview
10.11.4 Key Developments
10.12.2 Product/Business Segment Overview
10.12.4 Key Developments
10.13 Osiris Therapeutics
10.13.2 Product/Business Segment Overview
10.13.4 Key Developments